Based on the data retrieved from the TogoVar API, there is no mention of rs794727152 being included in pharmacogenomics guidelines such as PharmGKB. The variant is primarily associated with developmental and epileptic encephalopathy and other neurodevelopmental disorders, but no pharmacogenomic information is provided.

From external knowledge, PharmGKB focuses on variants with established roles in drug response, and rs794727152 does not appear to be listed in their database for pharmacogenomic relevance. If you are specifically looking for pharmacogenomic associations, it is recommended to consult the PharmGKB database directly for confirmation.

### English Summary:
- **Variant Identification**: rs794727152 is located in the SCN2A gene and has multiple transcript annotations, including NM_001040142.2:c.2558G>A (p.Arg853Gln) and NM_001040142.2:c.2558G>C (p.Arg853Pro).
- **Disease Associations**: Associated with developmental and epileptic encephalopathy, West syndrome, and other neurodevelopmental disorders.
- **Pharmacogenomics**: No evidence of inclusion in pharmacogenomics guidelines like PharmGKB.
- **TogoVar Link**: [TogoVar rs794727152](https://togovar.org/variant/tgv417503265)

### Japanese Summary:
- **バリアント識別**: rs794727152はSCN2A遺伝子に位置し、複数の転写産物注釈があります（例: NM_001040142.2:c.2558G>A (p.Arg853Gln) および NM_001040142.2:c.2558G>C (p.Arg853Pro)）。
- **疾患関連**: 発達性およびてんかん性脳症、West症候群、その他の神経発達障害に関連。
- **薬理ゲノミクス**: PharmGKBなどの薬理ゲノミクスガイドラインに含まれている証拠はありません。
- **TogoVarリンク**: [TogoVar rs794727152](https://togovar.org/variant/tgv417503265)